Skip to content
Loading…
Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.